AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimza-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Jarun Pharmaceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimza-M1 Tablet SR

Diabexa Duo SR tablets are antidiabetic medications combining two active ingredients for managing type 2 diabetes in adults. This formulation helps regulate blood glucose. Diabexa Duo SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels, increasing risks of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and trembling. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are essential. Alcohol consumption should be limited due to its hypoglycemic potential. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Prior heart conditions should be disclosed to your doctor before initiating treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (blood counts, liver function) are recommended.

Primary Ingredients of Glimza-M1 Tablet SR

No text provided. Please provide the text you wish to be rewritten.

Uses of Glimza-M1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimza-M1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimza-M1 Tablet SR with a meal.

Common Side effects of Glimza-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimza-M1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimza-M1 Tablet SR with a meal.

How Glimza-M1 Tablet SR works:

Glimza-M1 SR tablets contain a dual-action antidiabetic formula: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol consumption while taking Glimza-M1 SR tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimza-M1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimza-M1 tablets are contraindicated for use while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glimza-M1 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised. Glimza-M1 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimza-M1 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. A reduced initial dose of Glimza-M1 Tablet SR is typically advised for patients exhibiting mild to moderate liver dysfunction; its administration is contraindicated in those with severe hepatic disease.

What if you forget to take Glimza-M1 Tablet SR :

Should you forget a dose of Glimza-M1 Tablet SR, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimza-M1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimza-M1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimza-M1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimza-M1 Tablet SR and seek immediate medical attention.
Glimza-M1 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glimza-M1 SR tablets may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimza-M1 Tablet SR use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Glimza-M1 SR Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimza-M1 SR tablets and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimza-M1 Tablet SR
39
MRP 45
13% off